Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02761343 · ClinicalTrials.gov registry record · NA

MRI Assessment of Arrythmia Ablation Lesions

A NA study, sponsored by Children's National Research Institute.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT02761343: Completed NA study, sponsored by Children's National Research Institute.

NCT02761343 is a NA study that has completed, run by Children's National Research Institute. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02761343, a NA study, has completed, sponsored by Children's National Research Institute.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

This study will evaluate the feasibility of visualization and characterization of arrhythmia ablation lesions by MRI immediately following standard ablation techniques. The appearance of the ablation lesion will be correlated with clinical outcomes and risk of arrhythmia recurrence.

Interventions

  • OTHER MRI scan

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2014-04
Est. Completion 2020-01-18
Phase NA

What the finished NCT02761343 record still lists

NCT02761343 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which MRI scan is the first listed.

NCT02761343 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02761343 about?

NCT02761343 is a clinical study titled "MRI Assessment of Arrythmia Ablation Lesions". This study will evaluate the feasibility of visualization and characterization of arrhythmia ablation lesions by MRI immediately following standard ablation techniques. The appearance of the ablation lesion will be correlated with clinical outcomes and risk of arrhythmia recurrence.

What is the current status of trial NCT02761343?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2014-04. Estimated completion is 2020-01-18.

What interventions are being tested in trial NCT02761343?

The interventions under investigation include: MRI scan (OTHER).

Who is sponsoring clinical trial NCT02761343?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02761343's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02761343, the US trial registry maintained by the National Library of Medicine. NCT02761343 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.